OSLO, Norway, May 10, 2022 /PRNewswire/ Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, grew revenues with 7.4
The proposed acquisition reinforces Navamedic's position in the market for obesity treatmentThe acquired portfolio enables Navamedic to support patients and consumers during weight loss or obesity
OSLO, Norway, Feb. 17, 2022 /PRNewswire/ Navamedic ASA (OSE: NAVA) grew revenues by 63% in the fourth quarter of 2021 compared to the same quarter last year. The company reported revenues
OSLO, Norway, Feb. 16, 2022 /PRNewswire/ Navamedic ASA (OSE: NAVA) today announces the launch of SmectaGO for sale through pharmacies in Norway, Sweden, Finland and Denmark this spring. SmectaGO
OSLO, Norway, Nov. 4, 2021 /PRNewswire/ Navamedic ASA (OSE: NAVA) grew revenues by 12% in the third quarter of 2021 compared to the same quarter last year. The company reported revenues of